VITREOUS OPACITIES

This adverse event was reported 845 times

These drugs are most commonly taken by patients reporting VITREOUS OPACITIES:

# Drug Count
0 BROLUCIZUMAB 223
1 AFLIBERCEPT 191
2 RANIBIZUMAB 84
3 FARICIMAB 42
4 BEVACIZUMAB 41
5 DEXAMETHASONE 34
6 METHOTREXATE SODIUM 28
7 METHOTREXATE 27
8 TRIAMCINOLONE ACETONIDE 27
9 MOXIFLOXACIN HYDROCHLORIDE 26
See all common drugs associated with VITREOUS OPACITIES

VITREOUS OPACITIES is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BROLUCIZUMAB 223 0.0611
1 GREEN TEA LEAF 2 0.0500
2 VORETIGENE NEPARVOVEC-RZYL 5 0.0329
3 BALANCED SALT SOLUTION ENRICHED WITH BICARBONATE, DEXTROSE, AND GLUTATHIONE 6 0.0163
4 PHENYLEPHRINE AND KETOROLAC 1 0.0122
5 LEVOBUNOLOL HYDROCHLORIDE 1 0.0099
6 PEGCETACOPLAN 16 0.0084
7 SODIUM HYALURONATE 6 0.0073
8 AFLIBERCEPT 191 0.0061
9 AVACINCAPTAD PEGOL 2 0.0057
See all drugs enriched for association with VITREOUS OPACITIES